Clinical Trial Update: Pomalidomide for Chronic Graft-versus-Host Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of pomalidomide for chronic graft-versus-host disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Pomalidomide (Pomalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Graft vs Host Disease, Graft-Versus-Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-01-23